U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8250182501Effect of a Visual Nutrient Profiling System on Recall of Nutrition InformationCompletedNo Results AvailableHealthyBehavioral: Visual nutrient profiling tool|Behavioral: Nutrient ratings tablehttps://ClinicalTrials.gov/show/NCT01486147
8250282502Major RF Ablations of Hepatomas Under MR Thermometry MonitoringRecruitingNo Results AvailableHepatocellular CancerProcedure: Multipolar Radiofrequency ablationhttps://ClinicalTrials.gov/show/NCT01486134
8250382503Sedation Optimisation Strategy (S.O.S.) VentilationCompletedNo Results AvailableSurgery|Critical Illness|Mechanical Ventilation Complication|Organ Dysfunction Syndrome|Intensive Care Unit SyndromeOther: Therapy strategyhttps://ClinicalTrials.gov/show/NCT01486121
8250482504Burst Spinal Cord Stimulation for Neuropathic PainCompletedNo Results AvailableNeuropathic PainProcedure: dorsal column stimulatorhttps://ClinicalTrials.gov/show/NCT01486108
8250582505COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) StudyActive, not recruitingNo Results AvailableTrue Coronary Bifurcation LesionsDevice: AXXESS + Biomatrix Biolimus Eluting stent|Device: Culotte technique with Xience V or Xience Prime stentshttps://ClinicalTrials.gov/show/NCT01486095
8250682506Antimicrobial Susceptibility for Helicobacter Pylori EradicationRecruitingNo Results AvailableHelicobacter Pylori InfectionOther: OCA 10https://ClinicalTrials.gov/show/NCT01486082
8250782507Mandibular Stability and Dentofacial DeformityCompletedNo Results AvailableMaxillofacial Abnormalitieshttps://ClinicalTrials.gov/show/NCT01486069
8250882508ECG Vector DeterminationCompletedNo Results AvailableEpilepsyhttps://ClinicalTrials.gov/show/NCT01486056
8250982509Metformin and Transient HyperglycemiaTerminatedHas ResultsAcute Lymphoblastic Leukemia|Hyperglycemia|Insulin Resistance|Diabetes MellitusDrug: Metforminhttps://ClinicalTrials.gov/show/NCT01486043
8251082510Exercise Stress Testing on Peripheral Gene Expression Using CORUSâ„¢ CAD Diagnostic TestCompletedNo Results AvailableCoronary Artery Diseasehttps://ClinicalTrials.gov/show/NCT01486030
8251182511A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015KCompletedNo Results AvailableBioavailability of ASP015K|Pharmacokinetics of ASP015K|Healthy SubjectsDrug: ASP015Khttps://ClinicalTrials.gov/show/NCT01486017
8251282512A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive OvysmenCompletedNo Results AvailableHepatitis C VirusDrug: TMC435|Drug: Ovysmenhttps://ClinicalTrials.gov/show/NCT01486004
8251382513TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin TherapyCompletedHas ResultsHepatitis CDrug: TMC435|Drug: TVRhttps://ClinicalTrials.gov/show/NCT01485991
8251482514Efficacy and Safety Study to Delay Renal Failure in Children With Alport SyndromeRecruitingNo Results AvailableRenal Insufficiency, ChronicDrug: Ramipril|Drug: placebo to ramipril|Drug: Ramiprilhttps://ClinicalTrials.gov/show/NCT01485978
8251582515A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington DiseaseCompletedNo Results AvailableHuntington's DiseaseDrug: SEN0014196https://ClinicalTrials.gov/show/NCT01485965
8251682516An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196CompletedNo Results AvailableHuntington's DiseaseDrug: SEN0014196 (Low Dose)|Drug: SEN0014196 (High Dose)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01485952
8251782517Lidocaine Patch for Postoperative Analgesia After Laparoscopic CholecystectomyRecruitingNo Results AvailablePostoperative, PainOther: placebo patch applied|Other: 5% lidocaine patchhttps://ClinicalTrials.gov/show/NCT01485939
8251882518A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.Active, not recruitingNo Results AvailableBreast CancerDrug: Docetaxel, Carboplatin and Trastuzumab|Drug: Docetaxel, Carboplatin, Trastuzumab and Lapatinibhttps://ClinicalTrials.gov/show/NCT01485926
8251982519A Randomized Trial of an Intensive Education Intervention Using a Network of Involved Diabetic Patients (Peer Educators) to Improve Glycemic Control of Type 2 Diabetic PatientsActive, not recruitingNo Results AvailableDiabetesOther: intensive education intervention using a network of involved diabetic patients (peer educators)https://ClinicalTrials.gov/show/NCT01485913
8252082520Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I TreatmentCompletedNo Results AvailableChronic Kidney DiseaseDrug: SAR407899Ahttps://ClinicalTrials.gov/show/NCT01485900
8252182521Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)CompletedHas ResultsMajor Depressive DisorderDrug: Venlafaxine ERhttps://ClinicalTrials.gov/show/NCT01485887
8252282522Doxorubicin + BIBF 1120 in Patients for Ovarian CancerTerminatedNo Results AvailableOvarian CancerDrug: Doxil (Pegylated Liposomal Doxorubicin)|Drug: BIBF 1120https://ClinicalTrials.gov/show/NCT01485874
8252382523Study of GDC-0068 Or GDC-0980 With Abiraterone Acetate Versus Abiraterone Acetate in Patients With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel ChemotherapyActive, not recruitingNo Results AvailableProstate CancerDrug: GDC-0068|Drug: GDC-0068|Drug: GDC-0068|Drug: GDC-0980|Drug: abiraterone|Drug: placebo|Drug: prednisonehttps://ClinicalTrials.gov/show/NCT01485861
8252482524EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian CancerCompletedNo Results AvailableOvarian Cancer RecurrentDrug: EP-100|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT01485848
8252582525A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple MyelomaActive, not recruitingNo Results AvailableMultiple MyelomaDrug: Ganetespib|Drug: Bortezomib|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT01485835
8252682526A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic SolutionTerminatedNo Results AvailableOpen-angle GlaucomaProcedure: Trabecular Meshwork Tissue Collection|Drug: Travoprost 0.004% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT01485822
8252782527Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line ChemotherapyRecruitingNo Results AvailableSquamous Cell Carcinoma of BronchusDrug: Gefitinibhttps://ClinicalTrials.gov/show/NCT01485809
8252882528Tolerability and Safety of IGI, 10% With rHuPH20 in PIDDCompletedNo Results AvailablePrimary Immunodeficiency DisordersBiological: Immune Globulin Infusion (Human), 10%|Biological: Recombinant human hyaluronidasehttps://ClinicalTrials.gov/show/NCT01485796
8252982529Improving Outcomes for Hypertensive ChildrenCompletedNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT01485783
8253082530A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime SleepinessCompletedNo Results AvailableNarcolepsyDrug: ADX-N05|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01485770

* Görseller ve İçerik tekif hakkına sahip olabilir